Problem statement: Answer the multiple choice question.
Question: Which drug exhibits a -1.442% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a.) N#Cc1c(N)nc(SCC(=O)NCc2ccc3c(c2)OCO3)c(C#N)c1-c1cccs1
b.) Cc1cc(C)n(-c2ncnc3sc(C)c(C)c23)n1
c.) c1cc(-c2n[nH]c(-c3ccncc3)n2)ccn1
Answer: b. Cc1cc(C)n(-c2ncnc3sc(C)c(C)c23)n1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1cc(C)n(-c2ncnc3sc(C)c(C)c23)n1
Cc1cc(C)n(-c2ncnc3sc(C)c(C)c23)n1
4-(3,5-dimethylpyrazol-1-yl)-5,6-dimethylthieno[2,3-d]pyrimidine